Not applicableStudy completedNCT00512551What this trial is testingDNA Array Analysis of Patients With Cervical CancerWho this might be right forCervical Cancer M.D. Anderson Cancer Center 18
Not applicableEnded earlyNCT00624546What this trial is testingEffect of Antireflux Therapy on the Expression of Genes in Patients With GERDWho this might be right forGERDGastroesophageal Reflux University of Rochester 24
Not applicableStudy completedNCT01225679What this trial is testingLate-onset Congenital Central Hypoventilation Syndrome and the Mutation of Phox2B GeneWho this might be right forCongenital Central Hypoventilation Syndrome Associação Fundo de Incentivo à Pesquisa 1
Testing effectiveness (Phase 2)Study completedNCT04201756What this trial is testingNeoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung AdenocarcinomaWho this might be right forLung Adenocarcinoma Stage IIIEGFR Gene Mutation Shanghai Pulmonary Hospital, Shanghai, China 47
Not applicableStudy completedNCT02971969What this trial is testingLong-Term Safety, Tolerability, and Efficacy of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia BWho this might be right forHemophilia B Ultragenyx Pharmaceutical Inc 6
Early research (Phase 1)Ended earlyNCT00058773What this trial is testingGiving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin DiseaseWho this might be right forHodgkin DiseaseNon-Hodgkins Lymphoma Baylor College of Medicine 5
Testing effectiveness (Phase 2)Study completedNCT00004070What this trial is testingGene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck CancerWho this might be right forHead and Neck Cancer Dana-Farber Cancer Institute 7
Post-approval studies (Phase 4)UnknownNCT01339286What this trial is testingAssociated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD)Who this might be right forAttention Deficit Hyperactivity Disorder Peking University 100
Not applicableEnrolling By InvitationNCT04266093What this trial is testingGene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology StudiesWho this might be right forCervical Intraepithelial NeoplasiaCervical NeoplasmsOropharyngeal Neoplasms+2 more National Cancer Institute (NCI) 1,000
Not applicableStudy completedNCT00422721What this trial is testingGenetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal DystrophyWho this might be right forAmaurosisRetinal Diseases Nantes University Hospital 360
Early research (Phase 1)Study completedNCT00880464What this trial is testingAutologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast CancerWho this might be right forBreast Cancer Dana-Farber Cancer Institute 8
Testing effectiveness (Phase 2)Study completedNCT00876863What this trial is testingRandomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Sangamo Therapeutics 49
Testing effectiveness (Phase 2)UnknownNCT04613804What this trial is testingToripalimab as Maintenance Therapy in Patients With Driver-gene Negative Advanced NSCLC After First-line ChemotherapyWho this might be right forNSCLC Stage IV Fujian Cancer Hospital 30
Early research (Phase 1)Study completedNCT00002748What this trial is testingGene Therapy in Treating Children With Refractory or Recurrent NeuroblastomaWho this might be right forNeuroblastoma St. Jude Children's Research Hospital 38
Large-scale testing (Phase 3)Active Not RecruitingNCT05050084What this trial is testingTwo Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance TrialWho this might be right forProstate Adenocarcinoma NRG Oncology 2,050
Not applicableEnded earlyNCT01231932What this trial is testingCharacterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer SurvivorsWho this might be right forCancerFatigueProstate Cancer+2 more National Institute of Nursing Research (NINR) 163
Early research (Phase 1)Active Not RecruitingNCT02500849What this trial is testingSafety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected PatientsWho this might be right forHIV City of Hope Medical Center 12
Post-approval studies (Phase 4)Looking for participantsNCT05525338What this trial is testingComparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib BloodlevelsWho this might be right forDrug MonitoringCarcinoma, Non-Small-Cell LungLung Cancer+2 more University Medical Center Groningen 196
Early research (Phase 1)Study completedNCT01973543What this trial is testingSafety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's DiseaseWho this might be right forParkinson's Disease Neurocrine Biosciences 15
Testing effectiveness (Phase 2)Ended earlyNCT05070247What this trial is testingTAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid TumorsWho this might be right forPancreatic CancerHepatocellular CancerMesothelioma+7 more Takeda 61